Caribou Biosciences (CRBU) News Today $1.50 -0.02 (-0.99%) As of 09:40 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Brokers Issue Forecasts for CRBU FY2025 EarningsCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Caribou Biosciences in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Bienkowski anticipates that the company will earn ($1.31) per share foJanuary 23 at 9:26 AM | marketbeat.comThe Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc.(CRBU) ShareholdersJanuary 23 at 5:45 AM | prnewswire.comCRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud LawsuitJanuary 22 at 6:00 PM | prnewswire.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUJanuary 22 at 1:18 PM | globenewswire.comContact Levi & Korsinsky by February 24, 2025 Deadline to Join Class Action Against Caribou Biosciences, Inc. (CRBU)January 22 at 12:32 PM | globenewswire.comCRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJanuary 21 at 4:00 PM | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - CRBUJanuary 21 at 2:20 PM | prnewswire.comInvestors who lost money on Caribou Biosciences, Inc.(CRBU) should contact The Gross Law Firm about pending Class Action - CRBUJanuary 21 at 12:39 PM | globenewswire.comClass Action Filed Against Caribou Biosciences, Inc. ...January 21 at 6:12 AM | gurufocus.comClass Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact Levi & KorsinskyJanuary 21 at 5:45 AM | prnewswire.comCaribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The ...January 20 at 6:08 AM | gurufocus.comCaribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - CRBUJanuary 20 at 5:45 AM | prnewswire.comROSEN, NATIONAL INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. ...January 19, 2025 | gurufocus.comROSEN, NATIONAL INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUJanuary 19, 2025 | globenewswire.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUJanuary 18, 2025 | investing.comCRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud LawsuitJanuary 17, 2025 | prnewswire.comFaruqi & Faruqi Reminds Caribou Biosciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBUJanuary 17, 2025 | globenewswire.comCaribou Biosciences, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBUJanuary 17, 2025 | prnewswire.comROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUJanuary 16, 2025 | globenewswire.comClass Action Filed Against Caribou Biosciences, Inc. (CRBU) – February 24, 2025 Deadline to Join – Contact Levi & KorsinskyJanuary 16, 2025 | globenewswire.comCRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineJanuary 16, 2025 | prnewswire.comCRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJanuary 15, 2025 | globenewswire.comThe Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 – CRBUJanuary 15, 2025 | globenewswire.comCRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their OptionsJanuary 15, 2025 | prnewswire.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUJanuary 15, 2025 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - CRBUJanuary 14, 2025 | prnewswire.comInvestors in Caribou Biosciences, Inc. Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBUJanuary 14, 2025 | prnewswire.comCaribou Biosciences, Inc. Shareholders are Encouraged to Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the CRBU Class ActionJanuary 13, 2025 | globenewswire.comCaribou Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights – CRBUJanuary 13, 2025 | globenewswire.comCaribou Biosciences initiates CB-010 GALLOP Phase 1 trial in lupusJanuary 13, 2025 | markets.businessinsider.comShareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBUJanuary 13, 2025 | prnewswire.comCaribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025January 12, 2025 | globenewswire.comCRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud LawsuitJanuary 12, 2025 | gurufocus.comCRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud LawsuitJanuary 12, 2025 | prnewswire.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUJanuary 12, 2025 | globenewswire.comROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUJanuary 11, 2025 | investing.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUJanuary 10, 2025 | investing.comClass Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact Levi & KorsinskyJanuary 10, 2025 | prnewswire.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBUJanuary 9, 2025 | globenewswire.comShareholder Rights Law Firm Robbins LLP Reminds Stockholders of the CRBU Class Action and Urges Investors with Large Losses to Contact the Firm for Information About Participating in the CaseJanuary 9, 2025 | prnewswire.comCRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJanuary 9, 2025 | globenewswire.comClass Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law FirmJanuary 9, 2025 | prnewswire.comCaribou Biosciences price target lowered to $11 from $13 at BofAJanuary 8, 2025 | markets.businessinsider.comLevi & Korsinsky Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – CRBUJanuary 8, 2025 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - CRBUJanuary 8, 2025 | prnewswire.comFaruqi & Faruqi Reminds Caribou Biosciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBUJanuary 8, 2025 | prnewswire.comAnalysts Offer Predictions for CRBU FY2029 EarningsCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Equities research analysts at Brookline Capital Management issued their FY2029 EPS estimates for shares of Caribou Biosciences in a research report issued to clients and investors on Monday, January 6th. Brookline Capital Management analystJanuary 8, 2025 | marketbeat.comCRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud LawsuitJanuary 7, 2025 | prnewswire.comCaribou Biosciences, Inc. (NASDAQ:CRBU) Receives Consensus Recommendation of "Buy" from BrokeragesCaribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) has earned an average recommendation of "Buy" from the five analysts that are currently covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month price objJanuary 7, 2025 | marketbeat.comCRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJanuary 7, 2025 | prnewswire.com Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address CRBU Media Mentions By Week CRBU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRBU News Sentiment▼0.030.64▲Average Medical News Sentiment CRBU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRBU Articles This Week▼193▲CRBU Articles Average Week Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Opthea News Today Mind Medicine (MindMed) News Today Erasca News Today Verve Therapeutics News Today Stoke Therapeutics News Today Cartesian Therapeutics News Today MeiraGTx News Today Altimmune News Today ProKidney News Today AnaptysBio News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRBU) was last updated on 1/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caribou Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRBU Stock Alerts